Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
1992
882
LTM Revenue $294M
LTM EBITDA $72.2M
$611M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clinica Baviera has a last 12-month revenue of $294M and a last 12-month EBITDA of $72.2M.
In the most recent fiscal year, Clinica Baviera achieved revenue of $282M and an EBITDA of $83.9M.
Clinica Baviera expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Clinica Baviera valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $242M | $282M | XXX | XXX | XXX |
Gross Profit | $186M | $213M | XXX | XXX | XXX |
Gross Margin | 77% | 75% | XXX | XXX | XXX |
EBITDA | $72.2M | $83.9M | XXX | XXX | XXX |
EBITDA Margin | 30% | 30% | XXX | XXX | XXX |
Net Profit | $31.7M | $38.6M | XXX | XXX | XXX |
Net Margin | 13% | 14% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Clinica Baviera's stock price is EUR 34 (or $37).
Clinica Baviera has current market cap of EUR 544M (or $584M), and EV of EUR 569M (or $611M).
See Clinica Baviera trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$611M | $584M | XXX | XXX | XXX | XXX | $2.69 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Clinica Baviera has market cap of $584M and EV of $611M.
Clinica Baviera's trades at 2.1x LTM EV/Revenue multiple, and 8.5x LTM EBITDA.
Analysts estimate Clinica Baviera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Clinica Baviera and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $611M | XXX | XXX | XXX |
EV/Revenue | 2.2x | XXX | XXX | XXX |
EV/EBITDA | 7.3x | XXX | XXX | XXX |
P/E | 13.5x | XXX | XXX | XXX |
P/E/Growth | 1.6x | XXX | XXX | XXX |
EV/FCF | 15.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpClinica Baviera's NTM/LTM revenue growth is 13%
Clinica Baviera's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Clinica Baviera's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Clinica Baviera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Clinica Baviera and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 17% | XXX | XXX | XXX | XXX |
EBITDA Margin | 30% | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 42% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 67% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clinica Baviera acquired XXX companies to date.
Last acquisition by Clinica Baviera was XXXXXXXX, XXXXX XXXXX XXXXXX . Clinica Baviera acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Clinica Baviera founded? | Clinica Baviera was founded in 1992. |
Where is Clinica Baviera headquartered? | Clinica Baviera is headquartered in Spain. |
How many employees does Clinica Baviera have? | As of today, Clinica Baviera has 882 employees. |
Who is the CEO of Clinica Baviera? | Clinica Baviera's CEO is Mr. Eduardo Baviera Sabater. |
Is Clinica Baviera publicy listed? | Yes, Clinica Baviera is a public company listed on MAD. |
What is the stock symbol of Clinica Baviera? | Clinica Baviera trades under CBAV ticker. |
When did Clinica Baviera go public? | Clinica Baviera went public in 2000. |
Who are competitors of Clinica Baviera? | Similar companies to Clinica Baviera include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Clinica Baviera? | Clinica Baviera's current market cap is $584M |
What is the current revenue of Clinica Baviera? | Clinica Baviera's last 12-month revenue is $294M. |
What is the current EBITDA of Clinica Baviera? | Clinica Baviera's last 12-month EBITDA is $72.2M. |
What is the current EV/Revenue multiple of Clinica Baviera? | Current revenue multiple of Clinica Baviera is 2.1x. |
What is the current EV/EBITDA multiple of Clinica Baviera? | Current EBITDA multiple of Clinica Baviera is 8.5x. |
What is the current revenue growth of Clinica Baviera? | Clinica Baviera revenue growth between 2023 and 2024 was 17%. |
Is Clinica Baviera profitable? | Yes, Clinica Baviera is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.